Spring direct naar de hoofdnavigatie of de inhoud

Bart Jan Niestadt

Patent attorney

“The critical factors for a successful IP policy are different for each business. Knowing these factors is key.”
Home / Experts / Bart Jan Niestadt

Bart Jan Niestadt

Bart Jan Niestadt

  • Hightech & Electronics
  • European Patent Attorney
  • Dutch Patent Attorney
  • Belgian Patent Attorney
  • Senior Associate

Bart Jan Niestadt has been active as patent attorney from 2001 onwards. Before that, he had worked several years in the telecommunications industry, amongst others on network optimization and enhancements to network infrastructure, for BT-Infonet and Verizon Communications.

Bart Jan completed his studies of Applied Physics at Eindhoven University of Technology in 1997. His studies included an internship at ArizonaStateUniversity and a research project at Shell laboratories (SRTCA) in Amsterdam.

More information about Bart Jan

Throughout his career, Bart Jan has gained experience in litigation and opposition proceedings, and he is involved in a number of pending infringement cases in the telecommunications industry. In addition, he has a broad experience in preparing and prosecuting applications for small and large-sized enterprises in a wide range of technologies, and has developed commercial skills through a number of commercial activities and responsibilities over the years.

Working experience

  • Patent Attorney, V.O. (2011-present)
  • Patent Attorney, AOMB (2001-2011), head of Sittard office, AOMB (2009-2011)
  • Interxion (2001)
  • Verizon Communications (formerly: MCI-Worldcom) (2000-2001)
  • BT-Infonet (formerly: AT&T-Unisource) (1997-1999)

Education

  • MSc in Applied Physics, Eindhoven University of Technology (1997)

Publications

  • B.J. Niestadt: Twophase Flow in Cracking Furnaces. Residence Time in Annular Dispersed Flow and Bubble Detachment in Turbulent Flow, Eindhoven University of Technology, December 17, 1997.
  • H.J.S. Fernando, P. Peeters, A. Robles, and B. Niestadt: Laboratory Modeling of Microbursts, 1st AIAA Theoretical Fluid Mechanics Meeting, June 17-20, 1996, New Orleans, AIAA Paper 96-2149.

Languages

  • English
  • Dutch

Also see these experts

Jasper Groot Koerkamp

  • European Patent Attorney
  • Dutch Patent Attorney
  • Senior Associate

Dirk de Jong

  • European Patent Attorney
  • Dutch Patent Attorney
  • Associate
More experts

News

IP Academy well attended

This year’s IP Academy was scheduled between 1 and 15 November and saw broad participation from all sectors of our Dutch client database.Continue reading

Plants can be patentable after all

Classically bred plants should be held patentable once again. Last Wednesday the EPO Board of Appeal came to this remarkable decision. On July 1st last year the EPO – on explicit advice by the European member states – introduced guidelines that seemed to definitely exclude plants obtained by an essentially biological process from patentability. But […]Continue reading

The Ocean Cleanup at work

After an extensive trial phase with a U-shaped tube system, The Ocean Cleanup has finally begun to sweep the ocean clean, under the charismatic leadership of Boyan Slat. This all took place under an intense media spotlight.Continue reading

Events

Innovation for Health

World Trade Center (WTC) Rotterdam, Beursplein, Rotterdam

Innovation for Health is the premier event for key players in Health & Life Sciences in the Netherlands and Belgium. It provides a unique opportunity to meet leading innovators, to catch up on the latest trends, to present cutting-edge innovations and to engage leaders and decision makers in Life Sciences & Health. More about this event

Knowledge for Growth 2019

Gent ICC, Gent, België

Don’t miss the 2019 edition on 9 May  and capture the attention of 1,200 high-level life sciences actors from about 550 companies & organisations! The cream of the European life sciences community will be attending the 15th edition of flanders.bio’s annual knowledge for growth business conference, attracting decision makers from biotech, pharma and medtech as well as investors, universities, topnotch research institutes, policymakers and competence providers. More about this event